Stocks and Investing Stocks and Investing
Fri, February 2, 2024
Thu, February 1, 2024

Edward Tenthoff Maintained (APTO) at Buy with Decreased Target to $5 on, Feb 1st, 2024


Published on 2024-10-28 08:42:17 - WOPRAI, Edward Tenthoff
  Print publication without navigation


Edward Tenthoff of Piper Sandler, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $12 to $5 on, Feb 1st, 2024.

Edward has made no other calls on APTO in the last 4 months.



There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Edward's Rating of Hold.



This is the rating of the analyst that currently disagrees with Edward


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $18 on, Friday, November 10th, 2023
Contributing Sources